Mapping Antenatal Maternal Stress
MAMS
1 other identifier
observational
1,419
1 country
1
Brief Summary
This study recruits women from early-mid pregnancy and later follows their children after birth, tracking both the mother and child until the child reaches at least 4 years of age. The study aims to examine the determinants of maternal mental health during pregnancy and how genetic factors could influence maternal mental health and child outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2019
CompletedFirst Submitted
Initial submission to the registry
February 12, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 16, 2029
February 25, 2026
February 1, 2026
9.7 years
February 12, 2026
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cumulative psychosocial risk index of maternal depression and anxiety
To create a cumulative risk index by collecting data using existing validated measures on known risk factors for maternal depression and anxiety, including 1) low socio-economic status, 2) poor marital relations, 3) low social support, 4) high levels of perceived stress, 5) high levels of neuroticism, 6) low self-esteem, 7) poor family function, and 8) childhood adversity in the form of maltreatment and/or poor parental relations.
From pregnancy up to 2 years postnatal
Polygenic risk score for differential susceptibility to environmental susceptibility
To identify genotypic variation associated with perinatal maternal mental health
From pregnancy up to 2 years postnatal
Determinants of maternal symptoms of depression and anxiety with those that predict positive maternal mental health
To compare the determinants of maternal symptoms of depression and anxiety with those that predict the level of positive mental health
From pregnancy up to 2 years postnatal
Secondary Outcomes (3)
Influence of perinatal maternal mental health in relation to child development outcomes
From pregnancy to postnatal 6 years
Determine specific contribution of maternal prenatal mood factor components to specific developmental outcomes in children
From pregnancy to postnatal 6 years
Influence of genetic susceptibility on maternal mental health and child outcomes
From pregnancy to postnatal 6 years
Study Arms (1)
Pregnant mothers, infants and children
Mothers who are aged 21 - 40 years, below 24 weeks of pregnancy by ultrasonography, are willing to respond to questionnaires in English, and intend to stay in Singapore with her child for the next 5 years are eligible for the study. Babies born from these mothers will be followed up until the child is at least 4 years old.
Eligibility Criteria
Singapore
You may qualify if:
- Mothers aged 21 - 40 years
- Below 24 weeks of pregnancy by ultrasonography
- Proficient and able to respond to questionnaires in English
- Intends for herself and her child to stay in Singapore for the next 5 years
- Access to a smartphone or standard laptop/desktop
- All participants whose data on pregnancy follow-up and delivery would be available from healthcare professionals
- Willing to take part in this study and able to provide written consent
You may not qualify if:
- Women with pre-existing or a history of psychotic depression, schizophrenia and bipolar disorders
- Women currently on oral/IV steroids and/or thyroids medication
- Women with a history of thyroid disease
- Women who are pregnant via any assisted reproduction
- Women carrying multiples
- Women currently enrolled into any interventional randomized controlled trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Mental Health, Singaporecollaborator
- KK Women's and Children's Hospitalcollaborator
- Institute for Human Development and Potential (IHDP), Singaporelead
- National University Hospital, Singaporecollaborator
- McGill Faculty of Medicinecollaborator
Study Sites (1)
Institute for Human Development and Potential
Singapore, 117609, Singapore
Biospecimen
Collection of human biological materials, such as buccal, saliva and blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2026
First Posted
February 25, 2026
Study Start
September 30, 2019
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 16, 2029
Last Updated
February 25, 2026
Record last verified: 2026-02